Publications by authors named "A Logie"

Claim this Profile
P
Patient and Clinician Experiences With the Combination of Virtual and In-Person Chronic Kidney Disease Care Since the COVID-19 Pandemic.
Micheli Bevilacqua, Yuriy Melnyk, Helen Chiu, Janet Williams, Paul Watson, Anne Logie

Can J Kidney Health Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a Multistage Mixed-Methods Evaluation of Multidisciplinary Chronic Kidney Disease Care Quality Following Integration of Virtual and In-Person Care During the COVID-19 Pandemic.
Micheli Bevilacqua, Helen Chiu, Yuriy Melnyk, Janet Williams, Robin Chohan, Anne Logie

Can J Kidney Health Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
skn-1 is required for interneuron sensory integration and foraging behavior in Caenorhabditis elegans.
Mark A Wilson, Wendy B Iser, Tae Gen Son, Anne Logie, Joao V Cabral-Costa

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.
Nicola J Curtis, Lorraine Mooney, Lorna Hopcroft, Filippos Michopoulos, Nichola Whalley, Armelle Logie

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacokinetic-pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055.
James W T Yates, Sarah V Holt, Armelle Logie, Kirsty Payne, Karen Woods

Br J Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis